Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 2/2013

01-10-2013 | Review

Beta cell dynamics: beta cell replenishment, beta cell compensation and diabetes

Author: Marlon E. Cerf

Published in: Endocrine | Issue 2/2013

Login to get access

Abstract

Type 2 diabetes, characterized by persistent hyperglycemia, arises mostly from beta cell dysfunction and insulin resistance and remains a highly complex metabolic disease due to various stages in its pathogenesis. Glucose homeostasis is primarily regulated by insulin secretion from the beta cells in response to prevailing glycemia. Beta cell populations are dynamic as they respond to fluctuating insulin demand. Beta cell replenishment and death primarily regulate beta cell populations. Beta cells, pancreatic cells, and extra-pancreatic cells represent the three tiers for replenishing beta cells. In rodents, beta cell self-replenishment appears to be the dominant source for new beta cells supported by pancreatic cells (non-beta islet cells, acinar cells, and duct cells) and extra-pancreatic cells (liver, neural, and stem/progenitor cells). In humans, beta cell neogenesis from non-beta cells appears to be the dominant source of beta cell replenishment as limited beta cell self-replenishment occurs particularly in adulthood. Metabolic states of increased insulin demand trigger increased insulin synthesis and secretion from beta cells. Beta cells, therefore, adapt to support their physiology. Maintaining physiological beta cell populations is a strategy for targeting metabolic states of persistently increased insulin demand as in diabetes.
Literature
1.
K. Sekine, H. Taniguchi, Basics and applications of stem cells in the pancreas. J. Hepatobiliary Pancreat. Sci. 19(6), 594–599 (2012)PubMedCrossRef
2.
O. Cabrera, M.C. Jacques-Silva, D.M. Berman, A. Fachado, F. Echeverri, R. Poo, A. Khan, N.S. Kenyon, C. Ricordi, P.O. Berggren, A. Caicedo, Automated, high-throughput assays for evaluation of human pancreatic islet function. Cell Transpl. 16(10), 1039–1048 (2008)CrossRef
3.
H. Ichii, L. Inverardi, A. Pileggi, R.D. Molano, O. Cabrera, A. Caicedo, S. Messinger, Y. Kuroda, P.O. Berggren, C. Ricordi, A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. Am. J. Transpl. 5(7), 1635–1645 (2005)CrossRef
4.
M. Brissova, M.J. Fowler, W.E. Nicholson, A. Chu, B. Hirshberg, D.M. Harlan, A.C. Powers, Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J. Histochem. Cytochem. 53(9), 1087–1097 (2005)PubMedCrossRef
5.
C.N. Street, J.R. Lakey, A.M. Shapiro, S. Imes, R.V. Rajotte, E.A. Ryan, J.G. Lyon, T. Kin, J. Avila, T. Tsujimura, G.S. Korbutt, Islet graft assessment in the Edmonton Protocol: implications for predicting long-term clinical outcome. Diabetes 53(12), 3107–3114 (2004)PubMedCrossRef
6.
I. Todorov, I. Nair, A. Avakian-Mansoorian, J. Rawson, K. Omori, T. Ito, L. Valiente, I. Iglesias-Meza, C. Orr, K.D. Shiang, K. Ferreri, I.H. Al-Abdullah, Y. Mullen, F. Kandeel, Quantitative assessment of beta-cell apoptosis and cell composition of isolated, undisrupted human islets by laser scanning cytometry. Transplantation 90(8), 836–842 (2010)PubMedCrossRef
7.
Weir,G.C., Bonner-Weir, S: Islet beta cell mass in diabetes and how it relates to function, birth, and death. Ann. N. Y. Acad. Sci. (2013). doi:10.​1111/​nyas.​12031
8.
E. Tarabra, S. Pelengaris, M. Khan, A simple matter of life and death-the trials of postnatal beta-cell mass regulation. Int. J. Endocrinol. 2012, 516718 (2012)PubMed
9.
B. Xia, X.R. Zhan, R. Yi, B. Yang, Can pancreatic duct-derived progenitors be a source of islet regeneration? Biochem. Biophys. Res. Commun. 383(4), 383–385 (2009)PubMedCrossRef
10.
C. Demeterco, E. Hao, S.H. Lee, P. Itkin-Ansari, F. Levine, Adult human beta-cell neogenesis? Diabetes Obes. Metab. 11(Suppl. 4), 46–53 (2009)PubMedCrossRef
11.
P.A. Lysy, G.C. Weir, S. Bonner-Weir, Concise review: pancreas regeneration: recent advances and perspectives. Stem Cells Transl. Med. 1(2), 150–159 (2012)PubMedCrossRef
12.
L. Bouwens, I. Rooman, Regulation of pancreatic beta-cell mass. Physiol. Rev. 85(4), 1255–1270 (2005)PubMedCrossRef
13.
F.M. Ashcroft, P. Rorsman, Diabetes mellitus and the beta cell: the last ten years. Cell 148(6), 1160–1171 (2012)PubMedCrossRef
14.
Wu, J., Wu, J.J., Yang, L.J., Wei, L.X., Zou D.J.: Rosiglitazone protects against palmitate-induced pancreatic beta-cell death by activation of autophagy via 5′-AMP-activated protein kinase modulation. Endocrine (2012). doi:10.​1007/​s12020-012-9826-5
15.
M.Y. Donath, P.A. Halban, Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia 47(3), 581–589 (2004)PubMedCrossRef
16.
D.R. Green, B. Victor, The pantheon of the fallen: why are there so many forms of cell death? Trends Cell Biol. 22(11), 555–556 (2012)PubMedCrossRef
17.
D. Choi, M. Woo, Executioners of apoptosis in pancreatic beta-cells: not just for cell death. Am. J. Physiol. Endocrinol. Metab. 298(4), E735–E741 (2010)PubMedCrossRef
18.
E.L. Bradley, A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch. Surg. 128(5), 586–590 (1993)PubMedCrossRef
19.
K.Y. Hur, H.S. Jung, M.S. Lee, Role of autophagy in beta-cell function and mass. Diabetes Obes. Metab. 12(Suppl. 2), 20–26 (2010)PubMedCrossRef
20.
G. Las, O.S. Shirihai, The role of autophagy in beta-cell lipotoxicity and type 2 diabetes. Diabetes Obes. Metab. 12(Suppl. 2), 15–19 (2010)PubMedCrossRef
21.
M. Masini, M. Bugliani, R. Lupi, S. Del Guerra, U. Boggi, F. Filipponi, L. Marselli, P. Masiello, P. Marchetti, Autophagy in human type 2 diabetes pancreatic beta cells. Diabetologia 52(6), 1083–1086 (2009)PubMedCrossRef
22.
S.J. Dixon, K.M. Lemberg, M.R. Lamprecht, R. Skouta, E.M. Zaitsev, C.E. Gleason, D.N. Patel, A.J. Bauer, A.M. Cantley, W.S. Yang, B. Morrison, B.R. Stockwell, Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5), 1060–1072 (2012)PubMedCrossRef
23.
24.
B.Z. Stanger, A.J. Tanaka, D.A. Melton, Organ size is limited by the number of embryonic progenitor cells in the pancreas but not the liver. Nature 445(7130), 886–891 (2007)PubMedCrossRef
25.
B.E. Gregg, P.C. Moore, D. Demozay, B.A. Hall, M. Li, A. Husain, A.J. Wright, M.A. Atkinson, C.J. Rhodes, Formation of a human beta-cell population within pancreatic islets is set early in life. J. Clin. Endocrinol. Metab. 97(9), 3197–3206 (2012)PubMedCrossRef
26.
M.E. Cerf, Parental high-fat programming of offspring development, health and beta-cells. Islets 3(3), 118–120 (2011)PubMedCrossRef
27.
Y. Zhang, Y. Zhang, R.N. Bone, W. Cui, J.B. Peng, G.P. Siegal, H. Wang, H. Wu, Regeneration of pancreatic non beta endocrine cells in adult mice following a single diabetes-inducing dose of streptozotocin. PLoS ONE 7(5), e36675 (2012)PubMedCrossRef
28.
29.
I. Chambers, A. Smith, Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene 23(43), 7150–7160 (2004)PubMedCrossRef
30.
A.J. Becker, E.A. McCulloch, J.E. Till, Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature 197, 452–454 (1963)PubMedCrossRef
31.
O. Tavana, C. Zhu, Too many breaks (brakes): pancreatic beta-cell senescence leads to diabetes. Cell Cycle 10(15), 2471–2484 (2011)PubMedCrossRef
32.
Y. Dor, J. Brown, O.I. Martinez, D.A. Melton, Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429(6987), 41–46 (2004)PubMedCrossRef
33.
Y. Saisho, E. Manesso, A.E. Butler, R. Galasso, K. Kavanagh, M. Flynn, L. Zhang, P. Clark, T. Gurlo, G.M. Toffolo, C. Cobelli, J.D. Wagner, P.C. Butler, Ongoing beta-cell turnover in adult nonhuman primates is not adaptively increased in streptozotocin-induced diabetes. Diabetes 60(3), 848–856 (2011)PubMedCrossRef
34.
L. Bouwens, D.G. Pipeleers, Extra-insular beta cells associated with ductules are frequent in adult human pancreas. Diabetologia 41(6), 629–633 (1998)PubMedCrossRef
35.
J.J. Meier, J.C. Lin, A.E. Butler, R. Galasso, D.S. Martinez, P.C. Butler, Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia 49(8), 1838–1844 (2006)PubMedCrossRef
36.
M. Teta, M.M. Rankin, S.Y. Long, G.M. Stein, J.A. Kushner, Growth and regeneration of adult beta cells does not involve specialized progenitors. Dev. Cell 12(5), 817–826 (2007)PubMedCrossRef
37.
H. Liu, Y. Guz, M.H. Kedees, J. Winkler, G. Teitelman, Precursor cells in mouse islets generate new beta-cells in vivo during aging and after islet injury. Endocrinology 151(2), 520–528 (2010)PubMedCrossRef
38.
X. Xu, J. D’Hoker, G. Stange, S. Bonne, L.N. De, X. Xiao, M. Van De Casteele, G. Mellitzer, Z. Ling, D. Pipeleers, L. Bouwens, R. Scharfmann, G. Gradwohl, H. Heimberg, Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 132(2), 197–207 (2008)PubMedCrossRef
39.
F. Thorel, V. Nepote, I. Avril, K. Kohno, R. Desgraz, S. Chera, P.L. Herrera, Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature 464(7292), 1149–1154 (2010)PubMedCrossRef
40.
Z. Liu, W. Kim, Z. Chen, Y.K. Shin, O.D. Carlson, J.L. Fiori, Insulin and glucagon regulate pancreatic alpha-cell proliferation. PLoS ONE 6(1), e16096 (2011)PubMedCrossRef
41.
L.C. Murtaugh, D.A. Melton, Genes, signals, and lineages in pancreas development. Annu. Rev. Cell Dev. Biol. 19, 71–89 (2003)PubMedCrossRef
42.
Q. Zhou, J. Brown, A. Kanarek, J. Rajagopal, D.A. Melton, In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455(7213), 627–632 (2008)PubMedCrossRef
43.
E. Akinci, A. Banga, L.V. Greder, J.R. Dutton, J.M. Slack, Reprogramming of pancreatic exocrine cells towards a beta cell character using Pdx1, Ngn3 and MafA. Biochem. J. 442(3), 539–550 (2012)PubMedCrossRef
44.
S. Bonner-Weir, A. Inada, S. Yatoh, W.C. Li, T. Aye, E. Toschi, A. Sharma, Transdifferentiation of pancreatic ductal cells to endocrine beta-cells. Biochem. Soc. Trans. 36(Pt. 3), 353–356 (2008)PubMedCrossRef
45.
J. Shen, Y. Cheng, Q. Han, Y. Mu, W. Han, Generating insulin-producing cells for diabetic therapy: existing strategies and new development. Ageing Res. Rev. 12(2), 469–478 (2013)PubMedCrossRef
46.
M.E. Cerf, C.S. Chapman, J. Louw, High-fat programming of hyperglycemia, hyperinsulinemia, insulin resistance, hyperleptinemia, and altered islet architecture in 3-month-old wistar rats. ISRN Endocrinol. 2012, 627270 (2012)PubMed
47.
N. Swales, G.A. Martens, S. Bonne, Y. Heremans, R. Borup, M. Van De Casteele, Plasticity of adult human pancreatic duct cells by neurogenin3-mediated reprogramming. PLoS ONE 7(5), e37055 (2012)PubMedCrossRef
48.
A.M. Jamal, M. Lipsett, R. Sladek, S. Laganiere, S. Hanley, L. Rosenberg, Morphogenetic plasticity of adult human pancreatic islets of Langerhans. Cell Death Differ. 12(7), 702–712 (2005)PubMedCrossRef
49.
L. Shu, K. Zien, G. Gutjahr, J. Oberholzer, F. Pattou, J. Kerr-Conte, K. Maedler, TCF7L2 promotes beta cell regeneration in human and mouse pancreas. Diabetologia 55(12), 3296–3307 (2012)PubMedCrossRef
50.
R.M. Baertschiger, D. Bosco, P. Morel, V. Serre-Beinier, T. Berney, L.H. Buhler, C. Gonelle-Gispert, Mesenchymal stem cells derived from human exocrine pancreas express transcription factors implicated in beta-cell development. Pancreas 37(1), 75–84 (2008)PubMedCrossRef
51.
K.L. Seeberger, J.M. Dufour, A.M. Shapiro, J.R. Lakey, R.V. Rajotte, G.S. Korbutt, Expansion of mesenchymal stem cells from human pancreatic ductal epithelium. Lab. Invest. 86(2), 141–153 (2006)PubMedCrossRef
52.
J.M. Rossi, N.R. Dunn, B.L. Hogan, K.S. Zaret, Distinct mesodermal signals, including BMPs from the septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm. Genes Dev. 15(15), 1998–2009 (2001)PubMedCrossRef
53.
G. Deutsch, J. Jung, M. Zheng, J. Lora, K.S. Zaret, A bipotential precursor population for pancreas and liver within the embryonic endoderm. Development 128(6), 871–881 (2001)PubMed
54.
L. Yang, S. Li, H. Hatch, K. Ahrens, J.G. Cornelius, B.E. Petersen, In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc. Natl. Acad. Sci. U.S.A. 99(12), 8078–8083 (2002)PubMedCrossRef
55.
H. Kaneto, Y. Nakatani, T. Miyatsuka, T.A. Matsuoka, M. Matsuhisa, M. Hori, PDX-1/VP16 fusion protein, together with NeuroD or Ngn3, markedly induces insulin gene transcription and ameliorates glucose tolerance. Diabetes 54(4), 1009–1022 (2005)PubMedCrossRef
56.
Y.D. Song, E.J. Lee, P. Yashar, L.E. Pfaff, S.Y. Kim, J.L. Jameson, Islet cell differentiation in liver by combinatorial expression of transcription factors neurogenin-3, BETA2, and RIPE3b1. Biochem. Biophys. Res. Commun. 354(2), 334–339 (2007)PubMedCrossRef
57.
H. Motoyama, S. Ogawa, A. Kubo, S. Miwa, J. Nakayama, Y. Tagawa, In vitro reprogramming of adult hepatocytes into insulin-producing cells without viral vectors. Biochem. Biophys. Res. Commun. 385(1), 123–128 (2009)PubMedCrossRef
58.
V.K. Ramiya, M. Maraist, K.E. Arfors, D.A. Schatz, A.B. Peck, J.G. Cornelius, Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat. Med. 6(3), 278–282 (2000)PubMedCrossRef
59.
V. Yechoor, V. Liu, C. Espiritu, A. Paul, K. Oka, H. Kojima, L. Chan, Neurogenin3 is sufficient for transdetermination of hepatic progenitor cells into neo-islets in vivo but not transdifferentiation of hepatocytes. Dev. Cell 16(3), 358–373 (2009)PubMedCrossRef
60.
C. Rowe, C.E. Goldring, N.R. Kitteringham, R.E. Jenkins, B.S. Lane, C. Sanderson, V. Elliott, V. Platt, P. Metcalfe, B.K. Park, Network analysis of primary hepatocyte dedifferentiation using a shotgun proteomics approach. J. Proteome Res. 9(5), 2658–2668 (2010)PubMedCrossRef
61.
H. Edlund, Pancreatic organogenesis–developmental mechanisms and implications for therapy. Nat. Rev. Genet. 3(7), 524–532 (2002)PubMedCrossRef
62.
J.F. Habener, D.M. Kemp, M.K. Thomas, Minireview: transcriptional regulation in pancreatic development. Endocrinology 146(3), 1025–1034 (2005)PubMedCrossRef
63.
T. Kuwabara, M.N. Kagalwala, Y. Onuma, Y. Ito, M. Warashina, K. Terashima, T. Sanosaka, K. Nakashima, F.H. Gage, M. Asashima, Insulin biosynthesis in neuronal progenitors derived from adult hippocampus and the olfactory bulb. EMBO Mol. Med. 3(12), 742–754 (2011)PubMedCrossRef
64.
J.L. Plank, N.A. Mundell, A.Y. Frist, A.W. LeGrone, T. Kim, M.A. Musser, T.J. Walter, P.A. Labosky, Influence and timing of arrival of murine neural crest on pancreatic beta cell development and maturation. Dev. Biol. 349(2), 321–330 (2011)PubMedCrossRef
65.
N. Nekrep, J. Wang, T. Miyatsuka, M.S. German, Signals from the neural crest regulate beta-cell mass in the pancreas. Development 135(12), 2151–2160 (2008)PubMedCrossRef
66.
R.E. Burris, M. Hebrok, Pancreatic innervation in mouse development and beta-cell regeneration. Neuroscience 150(3), 592–602 (2007)PubMedCrossRef
67.
G. Grouwels, S. Vasylovska, J. Olerud, G. Leuckx, A. Ngamjariyawat, Y. Yuchi, L. Jansson, M. Van De Casteele, E.N. Kozlova, H. Heimberg, Differentiating neural crest stem cells induce proliferation of cultured rodent islet beta cells. Diabetologia 55(7), 2016–2025 (2012)PubMedCrossRef
68.
A.M. Holland, L.J. Gonez, L.C. Harrison, Progenitor cells in the adult pancreas. Diabetes Metab. Res. Rev. 20(1), 13–27 (2004)PubMedCrossRef
69.
S. Bonner-Weir, E. Toschi, A. Inada, P. Reitz, S.Y. Fonseca, T. Aye, A. Sharma, The pancreatic ductal epithelium serves as a potential pool of progenitor cells. Pediatr. Diabetes 5(Suppl. 2), 16–22 (2004)PubMedCrossRef
70.
C.S. Potten, M. Loeffler, Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 110(4), 1001–1020 (1990)PubMed
71.
72.
S. Weiss, B.A. Reynolds, A.L. Vescovi, C. Morshead, C.G. Craig, D. van der Kooy, Is there a neural stem cell in the mammalian forebrain? Trends Neurosci. 19(9), 387–393 (1996)PubMedCrossRef
73.
N.J. Blyth, Mechanisms and techniques of reprogramming-using PDX-1 homeobox protein as a novel treatment of insulin dependent diabetes mellitus. Diabetes Metab. Syndr. 6(2), 113–119 (2012)PubMedCrossRef
74.
E. Manesso, G.M. Toffolo, Y. Saisho, A.E. Butler, A.V. Matveyenko, C. Cobelli, P.C. Butler, Dynamics of beta-cell turnover: evidence for beta-cell turnover and regeneration from sources of beta-cells other than beta-cell replication in the HIP rat. Am. J. Physiol. Endocrinol. Metab. 297(2), E323–E330 (2009)PubMedCrossRef
75.
S.R. Smukler, M.E. Arntfield, R. Razavi, G. Bikopoulos, P. Karpowicz, R. Seaberg, F. Dai, S. Lee, R. Ahrens, P.E. Fraser, M.B. Wheeler, D. van der Kooy, The adult mouse and human pancreas contain rare multipotent stem cells that express insulin. Cell Stem Cell 8(3), 281–293 (2011)PubMedCrossRef
76.
R.M. Seaberg, S.R. Smukler, T.J. Kieffer, G. Enikolopov, Z. Asghar, M.B. Wheeler, G. Korbutt, D. van der Kooy, Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat. Biotechnol. 22(9), 1115–1124 (2004)PubMedCrossRef
77.
M.A. Goodell, K. Brose, G. Paradis, A.S. Conner, R.C. Mulligan, Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183(4), 1797–1806 (1996)PubMedCrossRef
78.
I. Banakh, L.J. Gonez, R.M. Sutherland, G. Naselli, L.C. Harrison, Adult pancreas side population cells expand after beta cell injury and are a source of insulin-secreting cells. PLoS ONE 7(11), e48977 (2012)PubMedCrossRef
79.
J. Dominguez-Bendala, C. Ricordi, Present and future cell therapies for pancreatic beta cell replenishment. World J. Gastroenterol. 18(47), 6876–6884 (2012)PubMedCrossRef
80.
L. Landsman, A. Nijagal, T.J. Whitchurch, R.L. Vanderlaan, W.E. Zimmer, T.C. Mackenzie, M. Hebrok, Pancreatic mesenchyme regulates epithelial organogenesis throughout development. PLoS Biol. 9(9), e1001143 (2011)PubMedCrossRef
81.
J.M. Slack, Developmental biology of the pancreas. Development 121(6), 1569–1580 (1995)PubMed
82.
S.C. Hanley, E. Austin, B. Assouline-Thomas, J. Kapeluto, J. Blaichman, M. Moosavi, M. Petropavlovskaia, L. Rosenberg, Beta-cell mass dynamics and islet cell plasticity in human type 2 diabetes. Endocrinology 151(4), 1462–1472 (2010)PubMedCrossRef
83.
M. Karaca, C. Magnan, C. Kargar, Functional pancreatic beta-cell mass: involvement in type 2 diabetes and therapeutic intervention. Diabetes Metab. 35(2), 77–84 (2009)PubMedCrossRef
84.
N. Kaiser, R. Nesher, M.Y. Donath, M. Fraenkel, V. Behar, C. Magnan, A. Ktorza, E. Cerasi, G. Leibowitz, Psammomys obesus, a model for environment-gene interactions in type 2 diabetes. Diabetes 54(Suppl. 2), S137–S144 (2005)PubMedCrossRef
85.
C. Bernard, C. Thibault, M.F. Berthault, C. Magnan, C. Saulnier, B. Portha, W.F. Pralong, L. Penicaud, A. Ktorza, Pancreatic beta-cell regeneration after 48-h glucose infusion in mildly diabetic rats is not correlated with functional improvement. Diabetes 47(7), 1058–1065 (1998)PubMedCrossRef
86.
87.
M. Brissova, M. Blaha, C. Spear, W. Nicholson, A. Radhika, M. Shiota, Reduced PDX-1 expression impairs islet response to insulin resistance and worsens glucose homeostasis. Am. J. Physiol. Endocrinol. Metab. 288(4), 707–714 (2005)CrossRef
88.
G. Kwon, C.A. Marshall, K.L. Pappan, M.S. Remedi, M.L. McDaniel, Signaling elements involved in the metabolic regulation of mTOR by nutrients, incretins, and growth factors in islets. Diabetes 53(3), S225–S232 (2004)PubMedCrossRef
89.
L.C. Alonso, T. Yokoe, P. Zhang, D.K. Scott, S.K. Kim, C.P. O’Donnell, Glucose infusion in mice: a new model to induce beta-cell replication. Diabetes 56(7), 1792–1801 (2007)PubMedCrossRef
90.
S. Bonner-Weir, D. Deery, J.L. Leahy, G.C. Weir, Compensatory growth of pancreatic beta-cells in adult rats after short-term glucose infusion. Diabetes 38(1), 49–53 (1989)PubMedCrossRef
91.
M. Paris, C. Bernard-Kargar, M.F. Berthault, L. Bouwens, A. Ktorza, Specific and combined effects of insulin and glucose on functional pancreatic beta-cell mass in vivo in adult rats. Endocrinology 144(6), 2717–2727 (2003)PubMedCrossRef
92.
S. Porat, N. Weinberg-Corem, S. Tornovsky-Babaey, R. Schyr-Ben-Haroush, A. Hija, M. Stolovich-Rain, Control of pancreatic beta cell regeneration by glucose metabolism. Cell Metab. 13(4), 440–449 (2011)PubMedCrossRef
93.
K. Brennand, D. Huangfu, D. Melton, All beta cells contribute equally to islet growth and maintenance. PLoS Biol. 5(7), e163 (2007)PubMedCrossRef
94.
M. Brissova, A. Shostak, M. Shiota, P.O. Wiebe, G. Poffenberger, J. Kantz, Pancreatic islet production of vascular endothelial growth factor-a is essential for islet vascularization, revascularization, and function. Diabetes 55(11), 2974–2985 (2006)PubMedCrossRef
95.
D.G. Pipeleers, F.C. Schuit, P.A. In’t Veld, E. Maes, E.L. Hooghe-Peters, M. Van de Winkel, Interplay of nutrients and hormones in the regulation of insulin release. Endocrinology 117(3), 824–833 (1985)PubMedCrossRef
96.
B. Thorens, Brain glucose sensing and neural regulation of insulin and glucagon secretion. Diabetes Obes. Metab. 13(1), 82–88 (2011)PubMedCrossRef
97.
Y. Zhang, M. Xiao, G. Niu, H. Tan, Mechanisms of oleic acid deterioration in insulin secretion: role in the pathogenesis of type 2 diabetes. Life Sci. 77(17), 2071–2081 (2005)PubMedCrossRef
98.
M.A. Kiraly, H.E. Bates, N.A. Kaniuk, J.T. Yue, J.H. Brumell, S.G. Matthews, M.C. Riddell, M. Vranic, Swim training prevents hyperglycemia in ZDF rats: mechanisms involved in the partial maintenance of beta-cell function. Am. J. Physiol. Endocrinol. Metab. 294(2), E271–E283 (2008)PubMedCrossRef
99.
C. Weyer, C. Bogardus, D.M. Mott, R.E. Pratley, The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J. Clin. Invest. 104(6), 787–794 (1999)PubMedCrossRef
100.
D.J. Withers, J.S. Gutierrez, H. Towery, D.J. Burks, J.M. Ren, S. Previs, Y. Zhang, D. Bernal, S. Pons, G.I. Shulman, S. Bonner-Weir, M.F. White, Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391(6670), 900–904 (1998)PubMedCrossRef
Metadata
Title
Beta cell dynamics: beta cell replenishment, beta cell compensation and diabetes
Author
Marlon E. Cerf
Publication date
01-10-2013
Publisher
Springer US
Published in
Endocrine / Issue 2/2013
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-013-9917-y

Other articles of this Issue 2/2013

Endocrine 2/2013 Go to the issue

Original Article

Association of polymorphisms in the leptin and leptin receptor genes with inflammatory mediators in patients with osteoporosis

Original Article

Vitamin D status and 5-year changes in urine albumin creatinine ratio and parathyroid hormone in a general population

Letter to the Editor

Subacute painful thyroiditis accompanied by scrub typhus infection

Review

The metabolic effects of growth hormone in adipose tissue

Editorial

Prophylactic central lymph node dissection in differentiated thyroid cancer

Original Article

Fisetin averts oxidative stress in pancreatic tissues of streptozotocin-induced diabetic rats
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits